Delcath Systems Files 8-K: Key Updates

Ticker: DCTH · Form: 8-K · Filed: Dec 30, 2024 · CIK: 872912

Sentiment: neutral

Topics: 8-K, disclosure, financials

TL;DR

Delcath Systems dropped an 8-K on 12/30 for 12/23 events - check it out!

AI Summary

Delcath Systems, Inc. filed an 8-K on December 30, 2024, reporting events that occurred on December 23, 2024. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located at 566 Queensbury Avenue, Queensbury, New York.

Why It Matters

This 8-K filing provides important updates and disclosures for Delcath Systems, Inc., which could impact investors' understanding of the company's current status and future outlook.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant corporate events, requiring careful review to assess potential risks and impacts.

Key Players & Entities

FAQ

What specific events are being disclosed under Regulation FD?

The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the header information.

What are the 'Other Events' being reported by Delcath Systems?

The filing lists 'Other Events' as an item, but the nature of these events is not detailed in the provided text.

What is the significance of the 'Financial Statements and Exhibits' being filed?

This indicates that the company is providing financial information and supporting documents as part of this 8-K filing.

When was Delcath Systems, Inc. incorporated and in which jurisdiction?

Delcath Systems, Inc. was incorporated in Delaware.

What is the primary business of Delcath Systems, Inc. according to its SIC code?

According to its Standard Industrial Classification (SIC) code [3841], Delcath Systems, Inc. is involved in 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.

Filing Stats: 1,011 words · 4 min read · ~3 pages · Grade level 12.4 · Accepted 2024-12-30 09:11:59

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 4.1 Form of Amendment Pre-Funded Warrant. 99.1 Press Release, dated December 30, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL (eXtensible Business Reporting Language) document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Delcath Systems, Inc. Date: December 30, 2024 By: /s/ Gerard Michel Name: Gerard Michel Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing